Risk factor
|
Categories
|
Nb
|
Ratio of geometric means (95 % CI) [P-value]
|
Nb
|
Ratio of geometric means (95 % CI) [P-value]
|
Parity
|
Primiparous
|
93
|
0.99 (0.86, 1.14) [0.890]
|
79
|
1.03 (0.89, 1.19) [0.698]
|
Multiparous
|
256
|
1c
|
212
|
1
|
Anti-malarial therapy
|
Artemisinin based
|
49
|
1.28 (1.09, 1.51) [0.003]
|
38
|
1.24 (1.07, 1.43) [0.003]
|
Non-artemisinin based
|
300
|
1
|
253
|
1
|
Symptoms
|
Symptomatic
|
232
|
0.89 (0.77, 1.03) [0.120]
|
211
|
0.94 (0.80, 1.11) [0.459]
|
Asymptomatic
|
88
|
1
|
80
|
1
|
Therapy supervision
|
Unsupervised
|
86
|
0.83 (0.73, 0.94) [0.004]
|
81
|
0.83 (0.73, 0.95) [0.006]
|
Supervised
|
253
|
1
|
210
|
1
|
Intercalated P. vivax
|
Yes
|
28
|
2.19 (1.77, 2.72) [<0.001]
|
25
|
2.19 (1.76, 2.73) [<0.001]
|
No
|
321
|
1
|
266
|
1
|
EGA (weeks)
|
349
|
349
|
1.00 (0.99, 1.00) [0.217]
|
291
|
1.00 (0.99, 1.00) [0.210]
|
Parasitaemia (m/L)d
|
349
|
349
|
0.98 (0.97, 1.00) [0.079]
|
291
|
0.98 (0.96, 0.99) [0.014]
|
Haematocrit (%)
|
327
|
327
|
1.00 (0.99, 1.01) [0.618]
|
291
|
1.00 (0.99, 1.01) [0.654]
|